The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
Abstract
We performed an individual patient meta-analysis to determine whether aspirin has a significant protective effect on the risk of first thrombosis among patients with antiphospholipid antibodies (aPL). Five international cohort studies with available individual patient-level data, reporting on primary prophylaxis with continuous treatment with low-dose aspirin in patients with aPL were included. The main outcome was the occurrence of a first thrombotic in patients with aPL treated with low-dose aspirin compared to those not treated with low-dose aspirin. Pooled Hazard Ratios (HRs) and 95%CIs were calculated using frailty models. We pooled data from 497 subjects and 79 first thrombotic events (3469 patient-years of follow-up). After adjustment on cardiovascular risk factors, aPL profiles, and treatment with hydroxychloroquine, the HR for the risk of a first thrombosis of any type in aPL carriers treated with low-dose aspirin versus those not treated with aspirin was 0.43 (95%CI 0.25-0.75). Subgroup analysis showed a protective effect of aspirin against arterial (HR: 0.43 [95%CI: 0.20-0.93]) but not venous (HR: 0.49 [95%CI: 0.22-1.11]) thrombosis. Subgroup analysis according to underlying disease revealed a protective effect of aspirin against arterial thrombosis for systemic lupus erythematosus (SLE) (HR: 0.43 [95%CI: 0.20-0.94]) and asymptomatic aPL carriers (HR: 0.43 [95%CI 0.20-0.93]). We found no independent protective effect of hydroxychloroquine. This individual patient data meta-analysis shows that the risk of first thrombotic event as well of first arterial thrombotic event is significantly decreased among SLE patients and asymptomatic aPL individuals treated by low-dose aspirin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In an individual patient analysis, this association was independent of the use of hydroxychloroquine (HCQ), suggesting that LDA offers additional benefit in this patient group.15”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [15]
In the citing paper
“An association of similar magnitude was present in a smaller individual patient meta-analysis derived from these studies.15”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [15]
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974
Ruiz-Irastorza, G., Cuadrado, M., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., Erkan, D., Krilis, S., Machin, S., Pengo, V, et al. (2011) · Lupus · doi:10.1177/0961203310395803 · Cited by 506
Pengo, V., Ruffatti, A., Legnani, C., Testa, S., Fierro, T., Marongiu, F., De Micheli, V., Gresele, P., Tonello, M., Ghirarduzzi, A., et al. (2011) · Blood · doi:10.1182/blood-2011-03-340232 · Cited by 468 · cited 1×
“Wepooled data from 2 prospective [11,13] and 3 retrospective [12,13, 17] cohort studies.”
BackgroundUrbanus, R. T., Siegerink, B., Roest, M., Rosendaal, F. R., de Groot, P. G., & Algra, A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70239-x · Cited by 429
Erkan, D., Harrison, M. J., Levy, R., Peterson, M., Petri, M., Sammaritano, L., Unalp‐Arida, A., Vilela, V., Yazici, Y., & Lockshin, M. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22663 · Cited by 401
Tektonidou, M. G., Laskari, K., Panagiotakos, D. B., & Moutsopoulos, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24232 · Cited by 356
Cited by
Sorted by citations
Items 101–146 of 146
Idiopathic Normal Pressure Hydrocephalus – What We Know
Baltatanu, D., & Berteanu, M. (2019) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2019.14.2.161 · Cited by 4
Nonanticoagulant Strategies for Venous Thromboembolism Prophylaxis
Gurumurthy, G., & Thachil, J. V. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2712-3534 · Cited by 3
Yamamoto, T., Matsushita, S., Endo, D., Shimada, A., Dohi, S., Kajimoto, K., Yokoyama, Y., Sato, Y. Z., Machida, Y., Asai, T., et al. (2023) · Medicine · doi:10.1097/md.0000000000032979 · Cited by 3
Viewpoint: Provoked thrombosis in antiphospholipid syndrome
Wahl, D. G., & Pengo, V. (2024) · Rheumatology · doi:10.1093/rheumatology/kead675 · Cited by 3
Addressing challenges in pediatric thrombosis: a comprehensive guideline development
Wang, Y., Yin, Q., Liao, J., Wang, N., Li, L., Li, S., Zhang, Q., Yu, F., Luo, J., Wang, H., et al. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1519517 · Cited by 3
Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery Occlusion
Consigli, A., Roquelaure, D., Souteyrand, G., Chizzolini, C., Thumann, G., & Chronopoulos, A. (2015) · Optometry and Vision Science · doi:10.1097/opx.0000000000000707 · Cited by 3
What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?
Ruiz‐Irastorza, G., & Khamashta, M. A. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2090338 · Cited by 3
Primordial and primary prevention in rheumatological diseases: The time has come.
Scagnellato, L., Salvato, M., Iorio, L., Moccaldi, B., Giollo, A., Zanatta, E., Padoan, R., Ramonda, R., & Doria, A. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103891 · Cited by 2
Andrade-Ortega, L., Xibille-Friedmann, D. X., Galarza-Delgado, D. Á., Saavedra, M. Á., Álvarez-Nemegyei, J., Castañeda, M. C. A., Fragoso-Loyo, H. E., Gordillo-Huerta, M. V., Irazoque-Palazuelos, F. C., Jara-Quezada, L. J., et al. (2024) · Reumatología Clínica · doi:10.1016/j.reuma.2024.07.004 · Cited by 2
Pascali, F. D., Filippova, Y. A., Donadini, M. P., Pengo, V., & Squizzato, A. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.109225 · Cited by 3
Antiphospholipid-Syndrom bei Kindern und Jugendlichen
Hedrich, C. M., & Kallinich, T. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-60410-6_39 · Cited by 2
Incomplete systemic lupus erythematosus. Own observation and literature review
Panafidina, T. A., Попкова, Т. В., Lila, A. M., & Nasonov, E. L. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2023-678-688 · Cited by 1
Clinical recommendations on diagnostics and treatment of lupus nephritis (draft project)
Zakharova, E., Kozlovskaya, N. L., Korotchaeva, Y. V., Bobkova, I. N., Dobronravov, V., & Karunnaya, A. V. (2024) · Nephrology and Dialysis · doi:10.28996/2618-9801-2024-2suppl-70-113 · Cited by 1
Update on Stroke Prevention and Treatment in Patients with Antiphospholipid Antibody Syndrome
Xeros, H. K., Bates, M. C., & Mustafa, R. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-025-00828-8 · Cited by 1
Primary Prophylaxis in Patients With Positive Antiphospholipid Antibodies
Cuadrado, M. J. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00015-6 · Cited by 1
Cottrell, J. N., Alsanani, A., Ogu, I., & Chaffin, D. G. (2022) · Transfusion Medicine and Hemotherapy · doi:10.1159/000526349 · Cited by 1
Incomplete systemic lupus erythematosus: terminology, diagnosis, course and therapy
Panafidina, T. A., Попкова, Т. В., & Lila, A. M. (2022) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2022-100-9-10-447-455 · Cited by 1
Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update
Andrade-Ortega, L., Xibille-Friedmann, D. X., Galarza-Delgado, D. Á., Saavedra, M. Á., Álvarez-Nemegyei, J., Castañeda, M. C. A., Fragoso-Loyo, H. E., Gordillo-Huerta, M. V., Irazoque-Palazuelos, F. C., Jara-Quezada, L. J., et al. (2024) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2024.10.003 · Cited by 1
Moyon, Q., Schmidt, M., Hertig, A., Fouret, P. J., Vauthier-Brouzes, D., Amoura, Z., & Aubart, F. C. (2019) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2019.03.001 · Cited by 1
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.012 · Cited by 1
Digital ulcers as presenting symptom of secondary antiphospholipid syndrome
Cravero, K., Maddy, A. J., & Motaparthi, K. (2022) · JAAD Case Reports · doi:10.1016/j.jdcr.2022.08.042 · Cited by 2
Chasset, F., Arnaud, L., & Francès, C. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.04.049 · Cited by 1
An unusual case of heart attack
Young, J. K.-Y., & Ng, D. K. H. (2018) · Hong Kong bulletin on rheumatic diseases · doi:10.2478/hkbrd-2018-0004
Síndrome de anticuerpos antifosfolípidos
Francès, C., & Chasset, F. (2018) · EMC - Dermatología · doi:10.1016/s1761-2896(18)92423-4
Rand, J. H., & Wolgast, L. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00141-4
Veselinović, M., Lucic, A. T., Jakovljevic, V. L., & Aničić, A. (2019) · Medicinski casopis · doi:10.5937/mckg53-23292
Manifestaciones cutáneas del síndrome antifosfolípido
Martínez, R. C., Merino, L. T., Mera, C. M., & Gullón, G. R. (2020) · Piel · doi:10.1016/j.piel.2019.12.015
Deficiency of natural anticoagulants: how should we manage cardiovascular prevention?
Paciullo, F., & Baccolo, A. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02712-0
Antiphospholipid-Syndrom bei Kindern und Jugendlichen
Hedrich, C. M., & Kallinich, T. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-60411-3_39-1
Arnaud, L., & van Vollenhoven, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-43035-5_7
Pérez, R. R. D. A. (2020) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2019.07.006
Arnaud, L., & van Vollenhoven, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-43035-5_4
Shovman, O., & Shoenfeld, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00032-4 · Cited by 1
Actualité du traitement du lupus en 2022
Arnaud, L. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77859-9.00003-7
Okorie, I. J., Appiah‐Kubi, E., Owusu‐Antwi, P., Takyi, E., Ugwendum, D. F., Fernando, A., Atere, M., & Nfonoyim, J. M. (2024) · Cureus · doi:10.7759/cureus.51819
Clinical aspects of antiphospholipid syndrome
Topilow, J., & Petri, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00051-4
Skin involvement in other autoimmune diseases
Xu, Y., Tian, J., Chen, J., Hu, Q., & Zhu, H. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00062-x
Síndrome de anticuerpos antifosfolípidos
Chasset, F. (2024) · EMC - Dermatología · doi:10.1016/s1761-2896(24)49754-9
Syndrome des anticorps antiphospholipides
Chasset, F. (2026) · Annales de Dermatologie et de Vénéréologie - FMC · doi:10.1016/j.fander.2026.06.002
Vidinikj, S., Antova, D., Bojadzioska, M., Gucev, F., Sandevska, E., Karadzova-Stojanoska, A., Pavlova, S., Vasilevska, A., Vidinikj, I., & Vejseli, R. (2025) · PRILOZI · doi:10.2478/prilozi-2025-0006
Syndrome des antiphospholipides
Yelnik, C., HACHULLA, E., & Lambert, M. (2025) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(24)47827-8
Zhang, Z., Li, F., Li, Y., Xie, Z., Du, J., Mao, N., Li, S., Liu, Y., Ge, Y., Wang, J., et al. (2026) · Lupus Science & Medicine · doi:10.1136/lupus-2026-001981
Aflaki, M., & Bargman, J. M. (2026) · Frontiers in Lupus · doi:10.3389/flupu.2026.1725054
Pengo, V., Poli, D., Sarti, L., Sivera, P., Barcellona, D., Prisco, D., Pizzini, A. M., Vercillo, G., Antonucci, E., Palareti, G., et al. (2026) · Thrombosis Research · doi:10.1016/j.thromres.2026.109786
Marisol, M. L. A., Paola, G. H. I., Alejandra, R. Z., & Alberto, A. V. L. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1882869
Metadata
- Authors
- Arnaud, L., Mathian, A., Devilliers, H., Ruffatti, A., Tektonidou, M., Forastiero, R., Pengo, V., Lambert, M., Lefevre, G., Martinez-Zamora, M. A., Balasch, J., Wahl, D., & Amoura, Z.
- Affiliations
- Inserm (FR)
- Sorbonne Université (FR)
- University of Padua (IT)
- National and Kapodistrian University of Athens (GR)
- Favaloro University (AR)
- Centre Hospitalier Universitaire de Lille (FR)
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Arnaud, Laurent
- ORCID
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 14
- Issue
- 3
- Pages
- 192-200
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2052413901
- Cited by
- 146
- References
- 30
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 20 · 2023: 8 · 2022: 12 · 2021: 10 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 12 · 2015: 13
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Autoimmunity Reviews (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- aspirin, antiphospholipid antibodies, low-dose aspirin, arterial thrombosis, venous thrombosis, systemic lupus erythematosus, hydroxychloroquine, individual patient data meta-analysis, thrombosis risk
- MeSH terms
- Aspirin, Humans, Primary Prevention, Risk Factors, Thrombosis, Cohort Studies, Treatment Outcome, Antibodies, Antiphospholipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
